More
    Guided Solutions - Connecting Talent With Innovation/div>

    Ronovo Surgical raises $67M for surgical robot, signs J&J collaboration

    Ronovo Surgical announced today that it closed its Series D financing round with a total investment of $67 million. Johnson & Johnson’s corporate venture capital...

    Boomerang Medical raises $20M for sacral neuromod tech for inflammatory bowel disease

    Boomerang Medical announced today that it raised $20 million in a Series B financing to support its implantable neuromodulation system. The women-led bioelectronic medicine company...

    Galvanize Therapeutics closes $100m Series C financing, hires new CEO

    Galvanize Therapeutics announced it raised $100 million and appointed Doug Godshall as chair and CEO. Godshall previously served as CEO of HeartWare before its $1...

    ViCentra raises $85m to drive insulin pump’s US market entry

    Dutch device company ViCentra has raised $85m to boost its Kaleido insulin patch pump’s entry onto the US market. According to the company, initial commercial...

    Berlin Heals Holding raises over $5m to advance heart failure treatment

    Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human...

    Cyted raises $44m to propel US market expansion of its endoscopic capsule

    UK-based Cyted Health has raised $44m to accelerate the ongoing market adoption of its EndoSign device in the US. The gastrointestinal (GI) diagnostic company’s EndoSign...

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based...

    Vaxxas raises $58.4M for needle-free vaccine delivery tech

    Vaxxas announced raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology. The Brisbane, Australia-based company picked up about $32...

    Avasa raises $2.8m pre-Series A for micro-artery coupling device

    Avasa completed the first close of its pre-Series A fundraising round worth about $2.8 million (NZD$4.75 million). Movac, one of New Zealand’s largest and longest-standing...

    Latest articles